急性心筋梗塞 (AMI) 診断における進歩:古典的なバイオマーカー,新興ツール,非侵襲的なサンプリングの増加

Desmond Chen Siong Sia¹, Hammad Mufti¹, Wei Hsum Yap¹

¹School of Biosciences, Faculty of Health and Medical Sciences, Taylor's University, 47500, Subang Jaya, Selangor, Malaysia.

Journal of cardiovascular translational research

|August 25, 2025

まとめ

急性心筋梗塞 (AMI) を早期に診断するための新しいバイオマーカーが有望である. 研究では唾液や尿などの非侵襲的なサンプルで心臓発作の早期発見と治療を試みています

科学分野:

心臓病とバイオマーカーの発見
分子診断
翻訳医学

背景:

急性心筋梗塞 (AMI) は世界の主要な死因であり,先進的な診断ツールが必要です.
現在進行中の心臓トロポニン検査は,早期発見と複雑な健康状態の患者に限られている.
診断戦略の改善は適切なタイミングで介入し患者の治療結果を改善するために不可欠です

研究の目的:

急性心筋梗塞 (AMI) の診断のための現在のおよび新興のバイオマーカーをレビューする.
AMIの早期発見のための非侵襲的な生物学的サンプルの可能性を調査する.
AMI診断技術における進歩の包括的な概要を提供すること.

主な方法:

従来のおよび新しいAMIバイオマーカーの文献レビュー.
新興バイオマーカークラスの評価:非コーディングRNA,細胞フリーDNA,エクソソーム,タンパク質,代謝産物.
非侵襲的なサンプル (唾液,尿) を用いて診断の可能性を評価する.

主要な成果:

従来のバイオマーカーは限界がありますが新しい候補は有望です
非侵襲的なサンプルは AMIを早期に検出する可能性を秘めています
検出技術の進歩によりバイオマーカーの感度と特異性が向上しています

結論:

新種のバイオマーカー,特に非侵襲的なソースは AMIの早期診断に革命をもたらします.
マルチマーカーアプローチとパーソナライズされた値は将来の診断戦略の鍵です.
非侵襲的なバイオマーカーの臨床検証は広く採用されるためには不可欠です

キーワード:

急性心筋梗塞心臓のバイオマーカー細胞フリーDNA 非コーディングRNA 非侵襲的な診断

さらに関連する動画

18:11

A Research Method For Detecting Transient Myocardial Ischemia In Patients With Suspected Acute Coronary Syndrome Using Continuous ST-segment Analysis

Published on: December 28, 2012

24.4K

07:28

Real-time Pressure-volume Analysis of Acute Myocardial Infarction in Mice

Published on: July 2, 2018

9.2K

関連する概念動画

01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...

01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

334

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

334

01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...

01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...

01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...

関連する実験動画